Literature DB >> 12361856

Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus.

Andrey Mazarati1, Claude G Wasterlain.   

Abstract

We compared the anticonvulsant actions of dynorphin A (1-13), galanin, neuropeptide Y and somatostatin in a model of self-sustaining status epilepticus (SSSE). SSSE was induced in adult Wistar rats by 30 min intermittent perforant path stimulation. Peptides or saline were injected into the hilus of the dentate gyrus 10 min after the end of perforant path stimulation. EEG was analyzed using Harmonie software (Stellate systems). While all neuropeptides showed significant seizure protecting effects, their anticonvulsant profiles followed different patterns: somatostatin and NPY induced strong, but transient suppression of spikes and seizures, while seizure suppression by dynorphin and galanin was more profound and irreversible.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12361856     DOI: 10.1016/s0304-3940(02)00847-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Gene therapy in epilepsy.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

2.  Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain.

Authors:  Manuel Alvarez-Dolado; Maria Elisa Calcagnotto; Kameel M Karkar; Derek G Southwell; Dorothy M Jones-Davis; Rosanne C Estrada; John L R Rubenstein; Arturo Alvarez-Buylla; Scott C Baraban
Journal:  J Neurosci       Date:  2006-07-12       Impact factor: 6.167

3.  GABA excitation in mouse hilar neuropeptide Y neurons.

Authors:  Li-Ying Fu; Anthony N van den Pol
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

Review 4.  Analgesic neuropeptide W suppresses seizures in the brain revealed by rational repositioning and peptide engineering.

Authors:  Brad R Green; Misty Smith; Karen L White; H Steve White; Grzegorz Bulaj
Journal:  ACS Chem Neurosci       Date:  2010-11-18       Impact factor: 4.418

Review 5.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Altered gene expression profile in a mouse model of SCN8A encephalopathy.

Authors:  Ryan S Sprissler; Jacy L Wagnon; Rosie K Bunton-Stasyshyn; Miriam H Meisler; Michael F Hammer
Journal:  Exp Neurol       Date:  2016-11-09       Impact factor: 5.330

Review 7.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

Review 8.  Neuronal plasticity in animal models and the epileptic human hippocampus.

Authors:  Gunther Sperk; Meinrad Drexel; Susanne Pirker
Journal:  Epilepsia       Date:  2009-12       Impact factor: 5.864

9.  Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus.

Authors:  Maxim Kozhemyakin; Karthik Rajasekaran; Marko S Todorovic; Samuel L Kowalski; Corinne Balint; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2013-03-05       Impact factor: 5.996

10.  Structural consequences of Kcna1 gene deletion and transfer in the mouse hippocampus.

Authors:  H Jürgen Wenzel; Helene Vacher; Eliana Clark; James S Trimmer; Angela L Lee; Robert M Sapolsky; Bruce L Tempel; Philip A Schwartzkroin
Journal:  Epilepsia       Date:  2007-07-25       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.